164 related articles for article (PubMed ID: 2475012)
1. Fluoxetine treatment of depression. Clinical effects, drug concentrations and monoamine metabolites and N-terminally extended substance P in cerebrospinal fluid.
Mårtensson B; Nyberg S; Toresson G; Brodin E; Bertilsson L
Acta Psychiatr Scand; 1989 Jun; 79(6):586-96. PubMed ID: 2475012
[TBL] [Abstract][Full Text] [Related]
2. Relationships between clinical symptoms and monoamine metabolite concentrations in biochemically defined subgroups of depressed patients.
Nordin C
Acta Psychiatr Scand; 1988 Dec; 78(6):720-9. PubMed ID: 2464903
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid monoamine metabolites in fluoxetine-treated patients with major depression and in healthy volunteers.
De Bellis MD; Geracioti TD; Altemus M; Kling MA
Biol Psychiatry; 1993 Apr 15-May 1; 33(8-9):636-41. PubMed ID: 7687151
[TBL] [Abstract][Full Text] [Related]
4. Correlated reductions in cerebrospinal fluid 5-HIAA and MHPG concentrations after treatment with selective serotonin reuptake inhibitors.
Sheline Y; Bardgett ME; Csernansky JG
J Clin Psychopharmacol; 1997 Feb; 17(1):11-4. PubMed ID: 9004051
[TBL] [Abstract][Full Text] [Related]
5. Effects of clomipramine treatment on cerebrospinal fluid monoamine metabolites and platelet 3H-imipramine binding and serotonin uptake and concentration in major depressive disorder.
Mårtensson B; Wägner A; Beck O; Brodin K; Montero D; Asberg M
Acta Psychiatr Scand; 1991 Feb; 83(2):125-33. PubMed ID: 1708190
[TBL] [Abstract][Full Text] [Related]
6. CSF monoamine metabolites in melancholia.
Asberg M; Bertilsson L; Mårtensson B; Scalia-Tomba GP; Thorén P; Träskman-Bendz L
Acta Psychiatr Scand; 1984 Mar; 69(3):201-19. PubMed ID: 6201041
[TBL] [Abstract][Full Text] [Related]
7. Relationships between glutamate and monoamine metabolites in cerebrospinal fluid and serum in healthy volunteers.
Alfredsson G; Wiesel FA; Tylec A
Biol Psychiatry; 1988 Apr; 23(7):689-97. PubMed ID: 2453224
[TBL] [Abstract][Full Text] [Related]
8. CSF amine metabolites and depression.
Peabody CA; Faull KF; King RJ; Whiteford HA; Barchas JD; Berger PA
Psychiatry Res; 1987 May; 21(1):1-7. PubMed ID: 2440071
[TBL] [Abstract][Full Text] [Related]
9. Monoamine metabolites in CSF and suicidal behavior.
Träskman L; Asberg M; Bertilsson L; Sjöstrand L
Arch Gen Psychiatry; 1981 Jun; 38(6):631-6. PubMed ID: 6166274
[TBL] [Abstract][Full Text] [Related]
10. A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression. II. Biochemical findings.
Aberg-Wistedt A; Ross SB; Jostell KG; Sjöquist B
Acta Psychiatr Scand; 1982 Jul; 66(1):66-82. PubMed ID: 6181652
[TBL] [Abstract][Full Text] [Related]
11. Selective antidepressants and cerebrospinal fluid. Lack of specificity on norepinephrine and serotonin metabolites.
Potter WZ; Scheinin M; Golden RN; Rudorfer MV; Cowdry RW; Calil HM; Ross RJ; Linnoila M
Arch Gen Psychiatry; 1985 Dec; 42(12):1171-7. PubMed ID: 2416297
[TBL] [Abstract][Full Text] [Related]
12. Monoamine metabolites in cerebrospinal fluid and serotonin uptake inhibition during treatment with chlorimipramine.
Asberg M; Ringberger VA; Sjöqvist F; Thorén P; Träskman L; Tuck JR
Clin Pharmacol Ther; 1977 Feb; 21(2):201-7. PubMed ID: 13959
[TBL] [Abstract][Full Text] [Related]
13. Monoamine metabolites in cerebrospinal fluid of depressed patients during treatment with mianserin or amitriptyline.
Mendlewicz J; Pinder RM; Stulemeijer SM; Van Dorth R
J Affect Disord; 1982 Sep; 4(3):219-26. PubMed ID: 6182175
[TBL] [Abstract][Full Text] [Related]
14. Monoamine metabolites in cerebrospinal fluid of depressive subgroups.
Rosenthal NE; Davenport Y; Cowdry RW; Webster MH; Goodwin FK
Psychiatry Res; 1980 Mar; 2(1):113-9. PubMed ID: 6158064
[TBL] [Abstract][Full Text] [Related]
15. Concentration gradients of monoamine metabolites in human cerebrospinal fluid.
Sjöström R; Ekstedt J; Anggård E
J Neurol Neurosurg Psychiatry; 1975 Jul; 38(7):666-8. PubMed ID: 1159438
[TBL] [Abstract][Full Text] [Related]
16. Antidepressant effect of femoxetine and desipramine and relationship to the concentration of amine metabolites in cerebrospinal fluid. A double-blind evaluation.
Dahl LE; Lundin L; le Fèvre Honoré P; Dencker SJ
Acta Psychiatr Scand; 1982 Jul; 66(1):9-17. PubMed ID: 6181653
[TBL] [Abstract][Full Text] [Related]
17. Bromocriptine treatment of depressive disorders. Clinical and biochemical effects.
Nordin C; Siwers B; Bertilsson L
Acta Psychiatr Scand; 1981 Jul; 64(1):25-33. PubMed ID: 6172006
[TBL] [Abstract][Full Text] [Related]
18. Platelet MAO activity and monoamine metabolites in cerebrospinal fluid in depressed and suicidal patients and in healthy controls.
Oreland L; Wiberg A; Asberg M; Träskman L; Sjöstrand L; Thorén P; Bertilsson L; Tybring G
Psychiatry Res; 1981 Feb; 4(1):21-9. PubMed ID: 6164071
[TBL] [Abstract][Full Text] [Related]
19. Amino acids in plasma and CSF and monoamine metabolites in CSF: interrelationship in healthy subjects.
Hagenfeldt L; Bjerkenstedt L; Edman G; Sedvall G; Wiesel FA
J Neurochem; 1984 Mar; 42(3):833-7. PubMed ID: 6198473
[TBL] [Abstract][Full Text] [Related]
20. CSF monoamine metabolites of depressed patients during illness and after recovery.
Träskman-Bendz L; Asberg M; Bertilsson L; Thorén P
Acta Psychiatr Scand; 1984 Apr; 69(4):333-42. PubMed ID: 6202099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
